Product Description
H7N9 Influenza Vaccine (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02436928)
Mechanisms of Action: Vaccine
Novel Mechanism: No
Modality: Vaccine
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Medigen Vaccine Biologics Corp.
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 2: Influenza in Birds|Influenza, Human
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| CT-MV-21 | P2 |
Completed |
Influenza, Human|Influenza in Birds |
2016-02-01 |
|
| NCT00123344 | N/A |
Completed |
Bradycardia|Atrial Fibrillation |
2007-06-01 |